Filing Details

Accession Number:
0000014272-19-000044
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-02-13 16:43:23
Reporting Period:
2018-04-30
Accepted Time:
2019-02-13 16:43:23
Original Submission Date:
2018-05-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
14272 Bristol Myers Squibb Co BMY Pharmaceutical Preparations (2834) 220790350
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1360224 C Dinesh Paliwal Bristol-Myers Squibb Company
430 E. 29Th Street, 14 Floor
New York NY 10016
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.10 Par Value Acquisiton 2018-04-30 9,540 $52.40 12,935 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $52.39 to $52.40, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
  2. Due to a software error, this Form 4 is being amended to report in Column 4 and Column 5 the correct amount of securities acquired and the correct number of securities beneficially owned following the reported transaction, respectively.